Senores Pharmaceuticals share price
You have to be logged in to add this to Watchlist.- ₹822.30(2.05%)November 7, 2025 15:41:08 PM IST
- NSE
- BSE
- Vol : 886.79K (NSE + BSE)Last 20 day avg : 379.94 K
Senores Pharmaceuticals is trading 2.05% upper at Rs 822.30 as compared to its last closing price. Senores Pharmaceuticals has been trading in the price range of 831.65 & 799.45. Senores Pharmaceuticals has given 36.06% in this year & 0.06% in the last 5 days. There are 4 analysts who have initiated coverage on Senores Pharmaceuticals. There are 2 analysts who have given it a strong buy rating & 2 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 19.73 Crores in its last quarter.Listed peers of Senores Pharmaceuticals include Utkarsh Small Finance Bank (-1.17%), Aeroflex Industries (3.23%), Senores Pharmaceuticals (2.05%).The Mutual Fund holding in Senores Pharmaceuticals was at 3.54% in 30 Sep 2025. The MF holding has increased from the last quarter. The FII holding in Senores Pharmaceuticals was at 4.28% in 30 Sep 2025. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Nov 08, 2025, 12:36 AM UTC
- Debt To EquityHigher than industry0.40The debt-to-equity ratio, indicating a company's financial leverage.
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- Dividend Yield-Annual dividends as a percentage of the stock price.
- Beta-Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
- Income
- Balance Sheet
- Cash Flow
- Financial
- Valuation
Company is profitable
The debt to equity of the company is higher than the industry median
- R1
- 817.67
- R2
- 861.08
- R3
- 890.52
- S1
- 744.82
- S2
- 715.38
- S3
- 671.97
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Utkarsh Small Finance Bank | Bearish | 16.92 | -1.17 | 2,996.95 | 109.82 | 0.89 | 2.07 | 79.16 |
| Aeroflex Industries | Neutral | 185.55 | 3.23 | 2,399.54 | 50.12 | 7.68 | 0.12 | 0.10 |
| Senores Pharmaceuticals | Bullish | 822.30 | 2.05 | 3,786.99 | 35.42 | 3.35 | - | 21.71 |
| Jubilant Agri And Consumer Produ | Bullish | 2,717.80 | 5.00 | 4,094.94 | 30.10 | 8.01 | - | 6.63 |
| Carraro India | Bullish | 505.00 | 0.22 | 2,873.00 | 29.47 | 5.67 | - | 31.54 |
- Promoter(s) holding is moderate at 45.80%
- Promoter(s) have increased the stake in the company in last 12 months
- FIIs are invested in this company
- FIIs holding has increased by 0.62 percentage points from previous quarter
- Mutual Funds holding has increased by 0.54 percentage points from previous quarter
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-11-06 | Quarterly Results |
| 2025-07-23 | Quarterly Results & Others |
| 2025-05-15 | Audited Results |
| 2025-01-23 | Quarterly Results & Others |
- Industry
- ISININE0RB801010
- BSE Code544319
- NSE CodeSENORES
Senores Pharmaceuticals is trading at 822.30 as on Fri Nov 07 2025 10:11:08. This is 2.05% upper as compared to its previous closing price of 805.80.
The market capitalization of Senores Pharmaceuticals is 3786.99 Cr as on Fri Nov 07 2025 10:11:08.
The average broker rating on Senores Pharmaceuticals is Strong Buy. The breakup of analyst rating is given below -
- 2 analysts have given a strong buy rating
- 2 analysts have given a buy rating
- 0.00 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Senores Pharmaceuticals is 829.55 whereas the 52 wk low is 440.00
Senores Pharmaceuticals can be analyzed on the following key metrics -
- TTM P/E:
- Sector P/E: 24.41
- Dividend Yield: %
- D/E ratio: -
Senores Pharmaceuticals reported a net profit of 58.56 Cr in 2025.
The Mutual Fund Shareholding was 3.54% at the end of 30 Sep 2025.